Barclays Capital Inc. bought and sold Osmotica Pharmaceuticals Plc shares, resulting in a net long position of 320 shares or 0.00%. The positive score for this news is 7.1949116318137385e-06. The neutral score for this news is 6.422754950108356e-07. The negative score for this news is 0.9999922513961792.